SciClone Plummets After Cutting Guidance, Says It's Not Talking To Any Acquirers
July 19, 2016 at 13:07 PM EDT
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) revealed an update on its tactical review process, which was disclosed in February. ...